Australia, July 18 -- Australia based Sanofi-Aventis Australia Pty Ltd has secured contract from National Blood Authority for Procurement of Imported Plasma and Recombinant Products (IPRP) - Eloctate and Alprolix. The value of the contract is worth 81,881,219.20 AUD.

Published by HT Digital Content Services with permission from Pivotal Sources....